#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hyperinsulinaemic hypoglycaemia Hypoparathyroidism Prostate cancer Frontotemporal dementia Osteosarcoma recurrent Burkitt's lymphoma refractory Hereditary ataxia Hypochondroplasia Diffuse large B-cell lymphoma refractory Immune-mediated myositis Hereditary optic atrophy Immune-mediated enterocolitis Myxofibrosarcoma Angiosarcoma Graft versus host disease More trials…

    Learn about Rare Diseases

    Hereditary optic atrophy – Basic Information Progressive multifocal leukoencephalopathy – Basic Information Primary immunodeficiency syndrome – Trials in Disease Aicardi-Goutieres syndrome – Life with Disease Lymphatic malformation – Treatment Niemann-Pick disease – Basic Information Marginal zone lymphoma – Life with Disease Mast cell activation syndrome – Life with Disease Factor IX deficiency – Basic Information Ewing’s sarcoma recurrent – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Buloxibutid Cd7-Cart01 Art0380 Mesilate Lib-01 Monohydrate Cls12311 Upacicalcet Sodium Hydrate AZD6234 Prednisolone Sodium Hyaluronate X-396 Glyceryl Trinitrate Nido-361 Afm24 Dsimc ATIGOTATUG Xanthum Gum Zamtocabtagene Autoleucel Dimeticone Amlodipine Piperacillin More therapies…

    Learn about Your Condition

    Ophthalmoplegia Cholestatic pruritus Obstructive airways disorder Perineal injury Loeys-Dietz syndrome Actinic cheilitis Mantle cell lymphoma stage III Psoriatic arthropathy Eosinophilic oesophagitis Mechanical ventilation Non-small cell lung cancer Circulatory collapse Bronchopulmonary aspergillosis Cold type haemolytic anaemia Polyneuropathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Stargardt’s disease

  • A study to evaluate the safety and tolerability of tinlarebant in patients with Stargardt disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Stargardt’s disease
    Investigated Drugs:
    • Tinlarebant
    Belgium France The Netherlands

  • Evaluation of SB-007 Safety and Efficacy in Patients with Stargardt Disease Type 1 (STGD1) Caused by ABCA4 Gene Mutations

    Recruiting

    2 1 1
    Investigated Drugs:
    • ADENO-ASSOCIATED VIRUS VECTOR SEROTYPE 8 ENCODING THE ABCA4 PROTEIN, C-REGION
    • ADENO-ASSOCIATED VIRUS VECTOR SEROTYPE 8 ENCODING THE ABCA4 PROTEIN, N-REGION
    Belgium Germany

  • Phase 3 Study of Gildeuretinol Acetate (ALK‑001) to Assess Safety and Efficacy in Slowing Progression of Stargardt Disease in Adults

    Not yet recruiting

    3 1
    Belgium France Germany Italy Spain

  • A study to evaluate the safety and effectiveness of AAVB-039 in patients with Stargardt disease

    Not yet recruiting

    2 1 1
    Belgium Italy The Netherlands Norway

  • Study on the Long-Term Safety of SAR422459 for Patients with Stargardt’s Disease

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Stargardt’s disease
    Investigated Drugs:
    • Lentiviral Vector Containing The Human Abca4 Gene
    France

  • Study on Tinlarebant for Treating Stargardt Disease in Adolescents

    Not recruiting

    3 1
    Investigated Drugs:
    • Tinlarebant
    Belgium France Germany The Netherlands

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!